Eagle Hitomi Technology-B (02251) rose more than 6%. As of press release, it was up 6.12% to HK$13.52, with a turnover of HK$1,9541 million.
The Zhitong Finance App learned that Eagle Eye Technology-B (02251) rose more than 6%. As of press release, it had risen 6.12% to HK$13.52, with a turnover of HK$1,9541 million.
According to the news, according to the latest data from the Hong Kong Stock Exchange, Tomasz Jakub Mialkos increased its holdings of Eagle Hitomi Technology's 55,000 H shares with an average price of HK$13.8106 per share on February 29, worth about HK$759,600. After the increase in holdings, Tomasz Jakub Mialkos's latest shareholding was 4.278,900 shares, and the good position ratio increased from 7.90% to 8.01%.
CICC's previous research report pointed out that while the company continues to promote a two-line layout inside and outside the hospital, it is also exploring overseas business. Currently, the company's products have obtained US FDA and European CE certifications, and the bank expects the company to continue contributing to overseas revenue in the future.